Team


Jan Dirk zurHausen

Dr. Jan zur Hausen
Founder and owner of Bergmann zur Hausen & Cie,
Frankfurt


Ph.D. in cell biology, BioCenter Basel (magna cum laude)
Biology undergraduate program, University of Hohenheim

- Senior Vice President Sal. Oppenheim, Head of Healthcare
  Investment Banking, Frankfurt
- Partner Deutsche Venture Capital GmbH (Deutsche Bank), Munich
- Member of the Executive Board Mulligan BioCapital AG, Hamburg
- Associate MPM Asset Management LLC, San Francisco, CA
- Analyst MPM Capital Advisors LLC, Boston, MA
- Research Associate Hoffmann-La Roche Ltd., Nutley, NJ



Peter Düllmann

Peter Düllmann
Director, Bergmann zur Hausen & Cie. GmbH


Post graduate Diploma of EFFAS
(European Federation of Financial Analysts Societies)
Diploma in Business Administration, FU Hagen
Degree in Pharmaceutics/Pharmacology, TU Braunschweig

- Executive Director LFG Kronos GmbH, Analyst Equity Research Healthcare,
  Frankfurt
- Associate Director Macquarie Capital (Europe) Ltd.,
  Head of Equity Research Healthcare (Europe), Frankfurt
- Senior Vice President Oppenheim Research GmbH,
  Head of Equity Research Healthcare (Europe), Cologne
- Associate Director WestLB Panmure, Analyst Equity Research Healthcare,
  Dusseldorf
- Marketing MSD Sharp & Dohme GmbH, Munich
- Deputy Head of a pharmacy, Oberhausen
- Lieutenant Commander at German Navy, Head of a pharmacy of the German
  armed forces, Wilhelmshaven


Bergmann zur Hausen & Cie. GmbH
An der Welle 4
60322 Frankfurt am Main
Tel: +49 69 95 63 01 21
Fax: +49 69 95 63 01 22
mail[at]bergmann-zurhausen.com
www.bergmann-zurhausen.com